Cookies on PerkinElmer
PerkinElmer uses cookies to ensure that we give you the best experience possible on our website. This may include cookies from third party websites. If you continue without changing your settings, we will assume that you consent to receive cookies from this website. You can change your cookie settings at any time. To learn more, please review our cookie policy, which includes information on how to manage your cookies.

For Faster Cures

Cancer, Parkinsons, Multiple Sclerosis, Zika. The list of deadly diseases and viruses that continue to challenge the scientific and medical community goes on. But PerkinElmer's latest technology is helping researchers go further. Our imaging solutions are allowing them to better visualize and understand cellular activity, phenotypes and drug treatments. Other applications of our disease research solutions include identifying staph infections, detecting dementia, and studying the effect of stem cells on neurotrauma.

Getting Closer. Going Further


Getting Closer. Going Further

How are new innovative solutions allowing researchers to understand and see more?


See how we can help

Better Stories

Better Products

Vectra Polaris Automated Quantitative Pathology Imaging System

Vectra® Polaris™ Automated Quantitative Pathology Imaging System

Our fully automated quantitative pathology system integrates both multispectral imaging and automated slide scanning to better visualize, quantify, and phenotype immune cells in situ in FFPE tissue sections and TMAs. Coupled with the power of inForm® image analysis software, Vectra Polaris allows easy detection and measurement of multiple overlapping biomarkers within a single tissue section.

Opera Phenix High-Content Screening System

Operetta Phenix™ High-Content Screening System

The premier confocal solution for today's most demanding high content applications. Drawing on over a decade of experience with the industry-leading Opera® High Content Screening System, the Opera Phenix is designed for high-throughput, phenotypic screening and assays involving complex disease models, such as live cells, primary cells and microtissues.

IVIS Spectrum In Vivo Imaging System

IVIS Spectrum In Vivo Imaging System

The IVIS® Spectrum In Vivo Imaging System uses a novel optical imaging technology to facilitate non-invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals. Its high-efficiency filters and spectral un-mixing algorithms let you take full advantage of bioluminescent and fluorescent reporters across the blue to near infrared wavelength region.

Want to hear more about our imaging solutions?


Start the conversation today

Innovative Thinking


Innovation in Cancer Immunology

Whether it’s making new drugs or testing what’s happening in the actual population. This is a first. Future studies using Single Cell ICP-MS will allow researchers to better understand metal uptake in cancer cells that will likely lead to new therapies not only for the treatment of ovarian cancer, but for a number of other cancers treated with metal based drugs.

Dr. Lauren Amable from the NIH shares her insights and what it means for the future of cancer treatments



Discover More...